Nutritional Supplement

Barberry

Parts Used & Where Grown

The root and stem bark contain the medicinally active components of barberry. The barberry bush also produces small red berries. Although this particular species is native to Europe, it now also grows throughout North America. A closely related species, Oregon grape (Berberis aquifolium), is native to North America.

How It Works

The alkaloid, berberine, receives the most research and widest acclaim as the active component of barberry and its relatives. Berberine is also a key constituent of goldenseal (Hydrastis canadensis). Berberine and its related constituents (such as oxyacanthine) are antibacterial1 and have been shown to kill amoebae in a test tube study.2 Berberine inhibits bacteria from attaching to human cells, which helps prevent infection.3 This compound treats diarrhea caused by bacteria, such as E. coli.4 Berberine also stimulates some immune system cells to function better.5 Berbamine is another alkaloid found in barberry. It may help reduce inflammation6 and is an antioxidant.7

The bitter compounds in barberry, including the alkaloids mentioned above, stimulate digestive function following meals.

References

1. Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: Antimicrobial activity, bioassay and mode of action. Can J Microbiol 1969;15:1067-76.

2. Subbaiah TV, Amin AH. Effect of berberine sulphate on Entamoeba histolytica. Nature 1967;215:527-8.

3. Sun D, Courtney HS, Beachey EH. Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Chemother 1988;32:1370-4.

4. Rabbani GH, Butler T, Knight J, et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 1987;155:979-84.

5. Kumazawa Y, Itagaki A, Fukumoto M, et al. Activation of peritoneal macrophages by berberine-type alkaloids in terms of induction of cytostatic activity. Int J Immunopharmacol 1984;6:587-92.

6. Wong CW, Seow WK, O'Callaghan JW, Thong YH. Comparative effects of tetrandrine and berbamine on subcutaneous air pouch inflammation induced by interleukin-1, tumour necrosis factor and platelet-activating factor. Agents Actions 1992;36:112-8.

7. Ju HS, Li XJ, Zhao BL, et al. Scavenging effect of berbamine on active oxygen radicals in phorbol ester-stimulated human polymorphonuclear leukocytes. Biochem Pharmacol 1990;39:1673-8.

8. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

9. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

10. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

11. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

12. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

13. Melchart D, Linde K, Worku F, et al. Immunomodulation with echinacea—a systematic review of controlled clinical trials. Phytomedicine 1994;1:245-54 [review].

14. Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed, Berlin: Springer, 1998, 168-73.

15. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 1998, 425-6.

16. Tewari JP, Srivastava MC, Bajpai JL. Pharmacologic studies of Achillea millefolium Linn. Indian J Med Sci 1994;28(8):331-6.

17. Khin-Maung-U, Myo-Khin, Nyunt-Nyunt-Wai, et al. Clinical trial of berberine in acute watery diarrhoea. Br Med J 1985;291:1601-5.

18. Gupte S. Use of berberine in treatment of giardiasis. Am J Dis Child 1975;129:866.

19. Choudhry VP, Sabir M, Bhide VN. Berberine in giardiasis. Indian Pediatr 1972;9:143-6.

20. Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol 1991;85:417-25.

21. Wiesenauer M, Lüdtke R. Mahonia aquifolium in patients with psoriasis vulgaris—an intraindividual study. Phytomedicine 1996;3:231-5.

22. Galle K, Müller-Jakic B, Proebstle A, et al. Analytical and pharmacological studies on Mahonia aquifolium. Phytomedicine 1994;1:59-62.

23. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

24. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

25. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

26. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

27. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

28. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press, 1985, 78.

29. Gruenwald J, Brendler T, Jaenicke C, et al. (eds). PDR for Herbal Medicines. Montvale, NJ: Medical Economics, 1998, 688-90.

30. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate 1993;63:201-8.

31. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 309-10.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.